Translational research is the process of applying knowledge from basic biology and clinical trials to techniques and tools that address unmet medical needs. It is specifically designed to improve health outcomes. Basic research is looking at questions related to how nature works, while translational research aims to take what's learned in basic research and apply that in the development of solutions to medical problems. Clinical research, then, takes those solutions and studies them in clinical trials.
At Prisys Biotechnology, we are committed to advancing the field of translational medicine, which aims to bridge the gap between basic research and clinical practice. Prisys Biotech is an innovative service provider of NHP disease models . Prisys Biotech has built a series of other NHP models for translational medicine.
- To provide the closest animal models to humans regarding genetics, physiology and behavior, and to facilitate the development of therapeutics, vaccines, devices or other interventions for human diseases.
- To support fundamental basic and translational biomedical research across many domains, such as infectious disease, immunology, social, cognitive, and behavioral research, reproduction, regenerative medicine, aging, neuroscience, etc.
- To validate the potential efficacy and safety of new molecules or vaccines before progressing to human clinical trials.
- To explore the mechanisms of disease pathogenesis, drug action, drug resistance, and biomarkers, and to identify new opportunities or research areas by using genetic, genomic, molecular, and imaging techniques.
By applying translational medicine, Prisys Biotech can help Researchers deepen our understanding of disease, explore the complex interactions between disease and the immune system, and discover predictive biomarkers that can guide the selection and combination of immunotherapies.
Our translational medicine team consists of experts from various disciplines, such as biomarkers, pathology, imaging, bioinformatics, pharmacology. They work together to provide scientific data and insights for our clients in hematology, immunology, fibrosis, and cardiovascular diseases etc.
In conclusion, translational medicine is a complex and systematic project that requires collaboration among multiple departments, disciplines, and fields. It can not only discover new targets from basic research, develop them into candidate compounds, and verify them through clinical studies, but also find unresolved safety and efficacy issues from new drug clinical studies, design solutions in reverse, and verify them through preclinical studies before returning to clinical trials.
